Background: The incidence of vancomycin-resistant enterococci (VRE) has reached endemic proportions in many medical centers. To initiate an effective infection control program, an understanding of the epidemiologic attributes of the genus in medical facilities is imperative. Methods: We studied 138 consecutive cases of VRE from April through December 1995. We created a database to analyze the risk factors for patients in both an adult hospital and a children's hospital and screened ail specimens, submitted for routine microbiologic analysis, for VRE. Results: One hundred twenty-three cases (89%) occurred in the adult acute care hospital, and 15 (11%) occurred in the children's hospital. Eighty patients (58%) were colonized with VRE, and 58 (42%) had an infection with VRE. Eighty-three percent of all the cases of VRE were nosocomially acquired. The majority of cases occurred in the medical service. Urine was the most important clinical specimen infected or colonized. Prior use of an antibiotic, other than vancomycin, was the most important risk factor for all nosocomial cases, followed by prior vancomycin use for surgical patients and residence in a unit with other patients infected with VRE for the medical service. Direct admission from another hospital was the most important risk factor for community-acquired cases. Special microbiologic screening of cultures yielded 48% of all VRE identified. Enterococcus faecium was the predominant resistant isolate recovered. Conclusions: The control of VRE in the hospital setting is difficult for several reasons. Almost half of all patients carrying VRE would not have been identified without special microbiologic screening efforts, as would patients, admitted from the community, who are already colonized with VRE. Controlling antibiotic use both in the hospital anc the community is basic for controlling these organisms. Continuous education of all staff about VRE and other nosocomially significant organisms is the key to controlling the spread of these bacteria.
机构:
Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USACtr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA
Tenover, FC
McDonald, LC
论文数: 0引用数: 0
h-index: 0
机构:
Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USACtr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA
机构:
Henry Ford Hosp, Div Infect Dis, Henry Ford Hlth Syst, Infect Prevent & Control, 2799 West Grand Blvd,CFP 302, Detroit, MI 48202 USAHenry Ford Hosp, Div Infect Dis, Henry Ford Hlth Syst, Infect Prevent & Control, 2799 West Grand Blvd,CFP 302, Detroit, MI 48202 USA
Reyes, Katherine
Bardossy, Ana Cecilia
论文数: 0引用数: 0
h-index: 0
机构:
Henry Ford Hlth Syst, Div Infect Dis, 2799 West Grand Blvd,CFP 302, Detroit, MI 48202 USAHenry Ford Hosp, Div Infect Dis, Henry Ford Hlth Syst, Infect Prevent & Control, 2799 West Grand Blvd,CFP 302, Detroit, MI 48202 USA
Bardossy, Ana Cecilia
Zervos, Marcus
论文数: 0引用数: 0
h-index: 0
机构:
Henry Ford Hlth Syst, Div Infect Dis, 2799 West Grand Blvd,CFP 302, Detroit, MI 48202 USA
Wayne State Univ, Sch Med, Detroit, MI USAHenry Ford Hosp, Div Infect Dis, Henry Ford Hlth Syst, Infect Prevent & Control, 2799 West Grand Blvd,CFP 302, Detroit, MI 48202 USA
机构:
Henry Ford Hosp, Div Infect Dis, CFP-3,2799 W Grand Blvd, Detroit, MI 48202 USAHenry Ford Hosp, Div Infect Dis, CFP-3,2799 W Grand Blvd, Detroit, MI 48202 USA
Joshi, Seema
Shallal, Anita
论文数: 0引用数: 0
h-index: 0
机构:
Henry Ford Hosp, Div Infect Dis, CFP-3,2799 W Grand Blvd, Detroit, MI 48202 USAHenry Ford Hosp, Div Infect Dis, CFP-3,2799 W Grand Blvd, Detroit, MI 48202 USA
Shallal, Anita
Zervos, Marcus
论文数: 0引用数: 0
h-index: 0
机构:
Wayne State Univ, CFP-3,2799 W Grand Blvd, Detroit, MI USAHenry Ford Hosp, Div Infect Dis, CFP-3,2799 W Grand Blvd, Detroit, MI 48202 USA